Cancer Medicine · 2021 · 13 citations · 19 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMolecular OncologyAngiogenesisAngiogenesis In CancerCancer Cell SignalingMicrotubule-associated ProteinsOvarian CancerAngiogenic ModulationCrispr-cas9 Genome EditingCrispr-cas9 KnockoutOvarian Cancer ChemotherapyOvarian Cancer PathogenesisOvarian Cancer TreatmentResistance To Antiangiogenic TherapyTumor Angiogenesis Signaling
Vasohibin-1 (VASH1) is a VEGF-inducible endothelium-derived angiogenesis inhibitor, and vasohibin-2 (VASH2), its homolog, exhibits proangiogenic activity. VASH2 is expressed by various cancer cells and accelerates tumor angiogenesis and progression. VASH2 was recently shown to exhibit tubulin carboxypeptidase (TCP) activity related to microtubule functions. Paclitaxel (PTX), an effective chemotherapeutic agent that is widely used to treat ovarian cancer, inhibits microtubule depolymerization and may interact with VASH2. We herein established several VASH2 knockout ovarian cancer cell lines using the CRISPR/Cas9 genome editing system to examine the intracellular tubulin detyrosination status and PTX chemosensitivity. The knockout of VASH2 did not affect the proliferation or sphere-forming activity of ovarian cancer cells in vitro. A Western blot analysis of VASH2 knockout cells revealed the weak expression of detyrosinated tubulin and upregulated expression of cyclin B1. The knockout of VASH2 significantly increased chemosensitivity to PTX, but not to cisplatin in ovarian cancer cell lines. The knockout of VASH2 reduced TCP activity and increased cyclin B1 expression, resulting in increased PTX chemosensitivity in ovarian cancer cells. The inhibition of angiogenesis and regulation of microtubule activity may be achieved in ovarian cancer treatment strategies targeting VASH2.
19
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jínek, Krzysztof Chylinski, Ines Fonfara et al. · Science · 2012 · 17.3K citations · Full text
Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2012 · 10.7K citations · Full text
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Peter Carmeliet, Valérie Ferreira, Georg Breier et al. · Nature · 1996 · 4.1K citations
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Napoleone Ferrara, Karen Carver-Moore, Helen Chen et al. · Nature · 1996 · 3.7K citations · Full text
Autocrine VEGF Signaling Is Required for Vascular Homeostasis
Sunyoung Lee, Tom T. Chen, Chad L. Barber et al. · Cell · 2007 · 1K citations · Full text